Literature DB >> 28478388

Management of a cutaneous squamous cell carcinoma overlying an AV fistula.

Neel Som Nath1, Brian F Gilmore2, Richard K McCann3, Paul J Mosca4.   

Abstract

Cutaneous squamous cell carcinoma (cSCC) currently affects over 700 000 patients per year in the USA alone, and its incidence continues to rise in recent years. A known risk factor for cSCC is chronic inflammation; a cSCC that develops at a site of chronic inflammation is known as Marjolin's ulcer. We present the case of a 76-year-old man with end-stage renal disease requiring chronic haemodialysis who developed an invasive cSCC at the cannulation site of an underlying arteriovenous (AV) fistula. In this instance, treatment with standard surgical excision or Mohs surgery would pose unique risks associated with injury to an otherwise functional AV fistula. Thus, the lesion was treated with electron beam radiation therapy, which offers a similar efficacy to surgery while minimising risk to the fistula. This resulted in a successful oncological outcome with no complications. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Dermatology; Radiotherapy; Skin cancer; Surgical oncology; Vascular surgery

Mesh:

Year:  2017        PMID: 28478388      PMCID: PMC5612344          DOI: 10.1136/bcr-2016-218932

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Cutaneous squamous-cell carcinoma.

Authors:  M Alam; D Ratner
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.

Authors:  B Hamouda; Z Jamila; R Najet; T Slim; N Rafiaa; B Noureddine; E M Ahmed; F Mohamed; K M Ridha; L Abderrahman
Journal:  J Am Acad Dermatol       Date:  2001-06       Impact factor: 11.527

3.  Interventions for non-metastatic squamous cell carcinoma of the skin: a summarised Cochrane review.

Authors: 
Journal:  Clin Exp Dermatol       Date:  2011-04       Impact factor: 3.470

4.  Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma.

Authors:  R Motley; P Kersey; C Lawrence
Journal:  Br J Dermatol       Date:  2002-01       Impact factor: 9.302

Review 5.  The epidemiology of UV induced skin cancer.

Authors:  B K Armstrong; A Kricker
Journal:  J Photochem Photobiol B       Date:  2001-10       Impact factor: 6.252

6.  Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.

Authors:  M R Karagas; T A Stukel; J S Morris; T D Tosteson; J E Weiss; S K Spencer; E R Greenberg
Journal:  Am J Epidemiol       Date:  2001-03-15       Impact factor: 4.897

7.  Squamous cell carcinoma in situ arising at the exit site of a tunneled catheter.

Authors:  John S Hammes; John T Bestoso; Amit Sharma
Journal:  Am J Kidney Dis       Date:  2004-09       Impact factor: 8.860

Review 8.  Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

Authors:  Daniel Berg; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2002-07       Impact factor: 11.527

9.  Outcomes after radiotherapy for squamous cell carcinoma of the eyelid.

Authors:  Janjira Petsuksiri; Steven J Frank; Adam S Garden; K Kian Ang; William H Morrison; K S Clifford Chao; David I Rosenthal; David L Schwartz; Anesa Ahamad; Bita Esmaeli
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

10.  The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden.

Authors:  Shehnaz K Hussain; Jan Sundquist; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2009-02-26       Impact factor: 8.551

View more
  1 in total

1.  Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative.

Authors:  Olivia M Lucero; Claudia Flores Echaiz; Fatemeh Jafarian; Matthew C Fox; John T Vetto; Reid V Mueller; Pedro G Teixeira; Fiona O Zwald; Justin J Leitenberger
Journal:  JAAD Case Rep       Date:  2018-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.